Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
The Oncologist|May 17, 2011
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancerDavid Miles, Henri Roché, Miguel Martin, et al.Cancers|April 30, 2021
Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast CancerAkshara Singareeka Raghavendra, Hala F Alameddine, Clark R Andersen, et al.Cancers|March 25, 2022
The Impact of Treatment for Smoking on Breast Cancer Patients' SurvivalAkshara Singareeka Raghavendra, George Kypriotakis, Maher Karam-Hage, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancerOlivier Graesslin, Bassam S Abdulkarim, Charles Coutant, et al.International Journal of Radiation Oncology, Biology, Physics|June 13, 2006
The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapySabin B Motwani, Eric A Strom, Naomi R Schechter, et al.Frontiers in Bioscience (Scholar Edition)|May 31, 2011
Immunologic mapping of glycomes: implications for cancer diagnosis and therapyDapeng Zhou, Steven B Levery, Fong-Fu Hsu, et al.The Oncologist|November 3, 2020
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast CancerBora Lim, Juhee Song, Nuhad K Ibrahim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancerJames L Murray, Michael E Gillogly, Donna Przepiorka, et al.Cancer Immunology Research|August 4, 2016
Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine TherapyBenedetto Farsaci, Renee N Donahue, Italia Grenga, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancerNuhad K Ibrahim, Kemal O Yariz, Ihor Bondarenko, et al.Pageof 7